|Articles|August 15, 2003

FDA rules to expedite generic drug marketing

Washington, DC-Drug companies will be limited to one 30-month stay of a generic drug's entry into the market under new FDA rules introduced by the federal Health and Human Services department.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME